1 www.smartermedicine.ch/fr
2 Neuner-Jehle S. Preventing Overdiagnosis and Overtreatment: Kranke Medizin. PrimaryCare. 2015;15(02):21.
Keller U, Wartmann R. Hausarztpraxis und Medikamenten-Management. PrimaryCare. 2015;15(16):285–28.
Neuner-Jehle S. Strategien gegen Polypharmazie. PrimaryCare. 2013;13(21):377.
Neuner-Jehle S. Zuviel des Guten – Rezepte gegen Polypharmazie. PrimaryCare 2011;11(12):212–15.
3 Garfinkel D, Mangin D. Feasability study of a systematic approach for discontinuation of multiple medications in older adults.
Arch Intern Med. 2010;170(18):1648–54.
4 Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–98.
5 Kuijpers MAJ, van Marum RJ, Egberts ACG, Jansen PAF. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2008;65(1):130–3.
6 Neuner-Jehle. Neuner-Jehle S, Krones T, Senn O. Systematisches Weglassen verschriebener Medikamente ist bei polymorbiden Hausarztpatienten akzeptiert und machbar. PRAXIS. 2014;103(6):
1–6.
7 www.choosingwisely.org
8 Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. The benefits and harms of deprescribing. Med J Aust. 2014;201(7):386–9.
9 Reeve E, Andrews JM, Wiese MD, Hendrix I, Roberts MS, Shakib S. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Ann Pharmacother. 2015;49(1):29–38.
10 Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.
11 Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9(6):430–4.
12 http://amsp.de/amsp-projekt/foerdervereine/sgamsp/